CY
Cynata Therapeutics Limited
CYYNF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $2.92M
P/E Ratio -
Div. Yield -
ROE 133.81%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
94 /100
Cheap P/S 1.55x
P/B 0.49x
P/E N/A
Growth
0 /100
Declining Rev. growth 37.63%
Book val. growth 37.03%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 465.24%
Net margin 498.14%
Quality
3 /100
Poor ROIC 135.81%
Asset turnover 0.26x
ROE 133.81%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.40x
Int. coverage N/A
Stability
19 /100
Unstable Beta 1.12x
Profitable years 0
Rev. volatility 59.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CYYNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kilian Kelly
Employees
2
Headquarters
Cremorne
Prihajajoči dogodki
25 FEB.
Earnings
Upcoming earnings report